China SXT Pharmaceuticals (SXTC) Invested Capital (2018 - 2026)
China SXT Pharmaceuticals (SXTC) posted quarterly Invested Capital of $355175.0 for Q1 2026, up 3944.81% year-over-year from $8781.0 in Q1 2025, and up 7836.87% quarter-over-quarter from $4475.0 in Q3 2025.
China SXT Pharmaceuticals (SXTC) Invested Capital (2018 - 2026) Analysis & Trends
China SXT Pharmaceuticals' Invested Capital history runs 9 years deep, the most recent figure standing at $355175.0 for Q1 2026.
- In Q1 2026, Invested Capital rose 3944.81% year-over-year to $355175.0; the TTM figure through Mar 2026 stood at $1.1 million (down 11.51% YoY), while the FY2026 annual figure was $355175.0, up 3944.81% from the prior year.
- Invested Capital for Q1 2026 stood at $355175.0, up from $4475.0 in the prior quarter.
- The five-year high for Invested Capital was $1.2 million in Q3 2022, with the low at $4475.0 in Q3 2025.
- The 5-year median for Invested Capital is $167453.0 (2023), against an average of $328272.8.
- The sharpest annual moves came in 2022 and 2024: Invested Capital sank 99.91% in 2022, then jumped 11960.87% in 2024.
- China SXT Pharmaceuticals' Invested Capital stood at $1.2 million in 2022, then sank by 99.52% to $5822.0 in 2023, then surged by 11960.87% to $702184.0 in 2024, then tumbled by 99.36% to $4475.0 in 2025, then surged by 7836.87% to $355175.0 in 2026.
- Business Quant data shows SXTC's Invested Capital at $355175.0 in Q1 2026, $4475.0 in Q3 2025, and $8781.0 in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Invested Cap. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.94 Bn | 42.97 Bn | - | 9.90 Bn |
| 2 | Teva Pharmaceutical Industries | 42.95 Bn | 39.30 Bn | 2.15 Bn | 4.50 Bn |
| 3 | Zoetis | 31.58 Bn | 29.90 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | 3.74 Bn |
| 5 | United Therapeutics | 22.16 Bn | 19.49 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | 1.74 Bn |
| 7 | Neurocrine Biosciences | 15.53 Bn | 15.14 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | 73.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.95 Bn | - | 630.00 Mn |
| 10 | China SXT Pharmaceuticals | 30,840.48 | -28.15 Mn | - | 355,175.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 355,175.00 |
| Sep 30, 2025 | 4,475.00 |
| Mar 31, 2025 | 8,781.00 |
| Sep 30, 2024 | 702,184.00 |
| Mar 31, 2024 | 493,054.00 |
| Sep 30, 2023 | 5,822.00 |
| Mar 31, 2023 | 167,453.00 |
| Sep 30, 2022 | 1.21 Mn |
| Mar 31, 2022 | 11,404.00 |
| Sep 30, 2021 | 2.12 Mn |
| Mar 31, 2021 | 12.15 Mn |
| Sep 30, 2020 | 45,757.00 |
| Mar 31, 2020 | 6.64 Mn |
| Sep 30, 2019 | 1.83 Mn |
| Mar 31, 2019 | 2.48 Mn |
| Sep 30, 2018 | 205,452.00 |